Trastuzumab Biosimilars Market Estimations (2025 - 2035)

Trastuzumab Biosimilars Market Estimations (2025 - 2035)

The trastuzumab biosimilars market covers biosimilars referencing Herceptin (trastuzumab), including intravenous lyophilised products and emerging subcutaneous trastuzumab-hyaluronidase biosimilars, for HER2-positive early and metastatic breast cancer and metastatic gastric and gastroesophageal junction cancer, supplied to hospitals and oncology clinics.

📄Report ID:2524 | 📊Format: Databook | 📅Published: 19 November 2026 | ⚡Delivery: Immediate